Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

combination therapy

  • You have access
    Cytokine-based Cancer Immunotherapy: Challenges and Opportunities for IL-10
    KATHRINE S. RALLIS, AMBER E. CORRIGAN, HASHIM DADAH, ALAN MATHEW GEORGE, SUMIRAT M. KESHWARA, MICHAIL SIDERIS and BERNADETT SZABADOS
    Anticancer Research July 2021, 41 (7) 3247-3252; DOI: https://doi.org/10.21873/anticanres.15110
  • Open Access
    Oral-recombinant Methioninase Converts an Osteosarcoma from Docetaxel-resistant to -Sensitive in a Clinically-relevant Patient-derived Orthotopic-xenograft (PDOX) Mouse Model
    YUSUKE AOKI, YASUNORI TOME, NATHANIEL F. WU, JUN YAMAMOTO, KAZUYUKI HAMADA, QINGHONG HAN, MICHAEL BOUVET, KOTARO NISHIDA and ROBERT M. HOFFMAN
    Anticancer Research April 2021, 41 (4) 1745-1751; DOI: https://doi.org/10.21873/anticanres.14939
  • You have access
    Anti-leukemic Activity of AIU2008 in FLT3-ITD-positive Acute Myeloid Leukemia
    HYO JEONG KIM, HWANI RYU, HYUN-KYUNG CHOI, JIE-YOUNG SONG, SANG-GU HWANG and JIYEON AHN
    Anticancer Research February 2021, 41 (2) 731-737; DOI: https://doi.org/10.21873/anticanres.14824
  • You have access
    Brucea javanica Increases Survival and Enhances Gemcitabine Efficacy in a Patient-derived Orthotopic Xenograft (PDOX) Mouse Model of Pancreatic Cancer
    HAITAO YANG, ZHONG TONG, LEI SHEN, YU SUN, ROBERT M. HOFFMAN and JUN HUANG
    Anticancer Research September 2020, 40 (9) 4969-4978; DOI: https://doi.org/10.21873/anticanres.14500
  • You have access
    Galloflavin Plus Metformin Treatment Impairs Pancreatic Cancer Cells
    EDGAR HEINZ UWE WENDT, MARIA SCHOENROGGE, BRIGITTE VOLLMAR and DIETMAR ZECHNER
    Anticancer Research January 2020, 40 (1) 153-160; DOI: https://doi.org/10.21873/anticanres.13936
  • You have access
    Combination of Trabectedin With Irinotecan, Leucovorin and 5-Fluorouracil Arrests Primary Colorectal Cancer in an Imageable Patient-derived Orthotopic Xenograft Mouse Model
    GUANGWEI ZHU, MING ZHAO, QINGHONG HAN, YUYING TAN, YU SUN, MICHAEL BOUVET, BRYAN CLARY, SHREE RAM SINGH, JIANXIN YE and ROBERT M. HOFFMAN
    Anticancer Research December 2019, 39 (12) 6463-6470; DOI: https://doi.org/10.21873/anticanres.13860
  • You have access
    Combination of Trabectedin With Oxaliplatinum and 5-Fluorouracil Arrests a Primary Colorectal Cancer in a Patient-derived Orthotopic Xenograft Mouse Model
    GUANGWEI ZHU, MING ZHAO, QINGHONG HAN, YUYING TAN, YU SUN, MICHAEL BOUVET, SHREE RAM SINGH, JIANXIN YE and ROBERT M. HOFFMAN
    Anticancer Research November 2019, 39 (11) 5999-6005; DOI: https://doi.org/10.21873/anticanres.13805
  • You have access
    Combination Treatment With Sorafenib and Everolimus Regresses a Doxorubicin-resistant Osteosarcoma in a PDOX Mouse Model
    TAKASHI HIGUCHI, NORIHIKO SUGISAWA, KENTARO MIYAKE, HIROMICHI OSHIRO, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, ZOEY KLINE, PAIGE BELT, SANT P. CHAWLA, MICHAEL BOUVET, SHREE RAM SINGH, HIROYUKI TSUCHIYA and ROBERT M. HOFFMAN
    Anticancer Research September 2019, 39 (9) 4781-4786; DOI: https://doi.org/10.21873/anticanres.13662
  • You have access
    Sorafenib and Palbociclib Combination Regresses a Cisplatinum-resistant Osteosarcoma in a PDOX Mouse Model
    TAKASHI HIGUCHI, NORIHIKO SUGISAWA, KENTARO MIYAKE, HIROMICHI OSHIRO, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, SANT P. CHAWLA, MICHAEL BOUVET, SHREE RAM SINGH, HIROYUKI TSUCHIYA and ROBERT M. HOFFMAN
    Anticancer Research August 2019, 39 (8) 4079-4084; DOI: https://doi.org/10.21873/anticanres.13565
  • You have access
    Cisplatin Augments Antitumor T-Cell Responses Leading to a Potent Therapeutic Effect in Combination With PD-L1 Blockade
    DAIKO WAKITA, TOSHIKI IWAI, SUGURU HARADA, MIHO SUZUKI, KANAME YAMAMOTO and MASAMICHI SUGIMOTO
    Anticancer Research April 2019, 39 (4) 1749-1760; DOI: https://doi.org/10.21873/anticanres.13281

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire